196 related articles for article (PubMed ID: 9431708)
1. Systemic treatment of severe psoriasis.
Georgouras KE; Zagarella SS; Cains GD; Brown PJ
Australas J Dermatol; 1997 Nov; 38(4):171-80; quiz 181-2. PubMed ID: 9431708
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic progress. II: Treatment of psoriasis.
Lewis HM
J Clin Pharm Ther; 1994 Aug; 19(4):223-32. PubMed ID: 7527403
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy for psoriasis.
Hönigsmann H
Clin Exp Dermatol; 2001 Jun; 26(4):343-50. PubMed ID: 11422187
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.
Warren RB; Griffiths CE
Clin Dermatol; 2008; 26(5):438-47. PubMed ID: 18755362
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis in children: a guide to its diagnosis and management.
Leman J; Burden D
Paediatr Drugs; 2001; 3(9):673-80. PubMed ID: 11688598
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis: current perspectives with an emphasis on treatment.
Linden KG; Weinstein GD
Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
[TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood psoriasis.
Ceović R; Pasić A; Lipozencić J; Murat-Susić S; Skerlev M; Husar K; Kostović K
Acta Dermatovenerol Croat; 2006; 14(4):261-4. PubMed ID: 17311742
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriasis. Part 2. Systemic therapies.
Lebwohl M; Ali S
J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
[TBL] [Abstract][Full Text] [Related]
9. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
Maryles S; Rozenblit M; Lebwohl M
J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
[TBL] [Abstract][Full Text] [Related]
10. Systemic and light therapies for the management of childhood psoriasis: part II.
Cordoro KM
Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
[TBL] [Abstract][Full Text] [Related]
12. [Prescription of phototherapy in psoriasis].
Beani JC
Rev Prat; 2004 Jan; 54(1):43-7. PubMed ID: 15049599
[TBL] [Abstract][Full Text] [Related]
13. [Systemic therapy of psoriasis].
Altmeyer P; Nüchel C
Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
[No Abstract] [Full Text] [Related]
14. Chronic plaque psoriasis.
Naldi L; Rzany B
Clin Evid; 2005 Jun; (13):2070-98. PubMed ID: 16135323
[No Abstract] [Full Text] [Related]
15. Psoriasis therapy: a current perspective.
Lowe NJ
West J Med; 1983 Aug; 139(2):184-9. PubMed ID: 6195826
[TBL] [Abstract][Full Text] [Related]
16. Treatment of moderate-to-severe plaque psoriasis.
Salgo R; Thaçi D
G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Stiefelhagen P
MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277
[No Abstract] [Full Text] [Related]
18. Management of patients with psoriasis.
Croney S
Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic management of psoriasis].
Guilhou JJ
Ann Dermatol Venereol; 1996; 123(4):276-9. PubMed ID: 8763756
[No Abstract] [Full Text] [Related]
20. Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.
Papp KA; Toth D; Rosoph L
BMC Dermatol; 2006 Oct; 6():9. PubMed ID: 17067371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
